Evidence Synthesis
KOLTEPATIL posted a 25.51% gross margin, accelerating from -3.86% in the last quarter.
The company's marginal operating leverage .86% improved from .26% in the last quarter.
By paying you agree to our Terms and Privacy Policy.
Evidence Synthesis
Last synthesized: 9 Jul 2026, 14:37
Evidence Synthesis
KOLTEPATIL posted a 25.51% gross margin, accelerating from -3.86% in the last quarter.
The company's marginal operating leverage .86% improved from .26% in the last quarter.
Source observations behind the synthesis narrative.
| Metric | Value | Previous Value | Trend |
|---|---|---|---|
| GROSS_MARGIN | 25.51 % | -3.86 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -3.86 % | -5.26 | ▲ |
| REVENUE_GROWTH_YOY | -65.4 % | — | - |
| EPS_ACTUAL | -2.21 INR | -1.18 | ▼ |
| EPS_SURPRISE_PERCENT | -1.356 % | -1.182 | ▼ |
| PRICE_CHANGE_PERCENT | -2.873 % | — | - |
| DAILY_VOLUME | 19,878 shares | 1,79,838 | ▼ |
| CLOSE_PRICE | 356.6 INR | 367.15 | ▼ |
| NEWS_SENTIMENT_SCORE | 1 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 0 count | 4 | ▼ |
| TARGET_PRICE_PREMIUM | 34.04 % | — | - |